Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Poly-Med Inc. has 5 pending office actions in Chemistry & Materials. The matters involve 4 examiners across 4 art units, so one examiner has more than one matter while each art unit is represented separately.
WORRELL, KEVIN is the busiest examiner, with 2 pending matters. This makes that examiner the most useful point for checking whether related claim issues or response strategies can be coordinated. The separate art-unit assignments mean that any common approach should still account for the practices of each examining group.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BYRD, BRIGID K | 1 | 71.4% | +46.4% |
| CAI, WENWEN | 1 | 59.9% | +19.4% |
| WORRELL, KEVIN | 1 | 12.5% | -3.1% |
| GHALI, ISIS A D | 1 | 27.9% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15301281 | CONTRACEPTIVE AND RELATED DEVICE | GHALI, ISIS A D | 26d |
| 18604036 | POLYMERIC MESH PRODUCTS, METHOD OF MAKING AND USE THEREOF | WORRELL, KEVIN | 70d |
| 18937342 | POLYMERS FOR ADDITIVE MANUFACTURING | CAI, WENWEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15301281 | CONTRACEPTIVE AND RELATED DEVICE | GHALI, ISIS A D | 26d |
| 19197122 | TIME DEPENDENT PHYSIOLOGIC TISSUE SCAFFOLD | BYRD, BRIGID K | — |
| 18937342 | POLYMERS FOR ADDITIVE MANUFACTURING | CAI, WENWEN | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| 1743 | 1 |
| 1789 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19197122 | TIME DEPENDENT PHYSIOLOGIC TISSUE SCAFFOLD | BYRD, BRIGID K | 3771 | §102§103§112DP | Non-Final OA | — | Pending | May 02, 2025 |
| 18937342 | POLYMERS FOR ADDITIVE MANUFACTURING | CAI, WENWEN | 1743 | §102§103§112 | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18604036 | POLYMERIC MESH PRODUCTS, METHOD OF MAKING AND USE THEREOF | WORRELL, KEVIN | 1789 | DP | Non-Final OA | 70d | Pending | Mar 13, 2024 |
| 15301281 | CONTRACEPTIVE AND RELATED DEVICE | GHALI, ISIS A D | 1611 | §103 | Final Rejection | 26d | Pending | Sep 30, 2016 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPoly-Med Inc. has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Brigid K Byrd has the most, with 1 of Poly-Med Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
